II. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia

D. W. Bilheimer, C. East, Scott M Grundy, J. J. Nora

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We have studied a family carrying a variant of the class 2 mutation of familial hypercholesterolemia (FH) in which there is unusual longevity and in which obligate heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes have the same kinetic defect in the processing of low density lipoprotein (LDL) receptors their fibroblasts and the reduced fractional catabolic rate for apoLDL that is characteristic of other patients with heterozygotes FH. However, their plasma lipid and lipoprotein levels are not as strikingly abnormal because they have normal or near normal rates of apoLDL synthesis.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalAmerican Journal of Medical Genetics
Volume22
Issue number3
StatePublished - 1985

Fingerprint

Hyperlipoproteinemia Type II
LDL Receptors
Heterozygote
Mutation
Hypercholesterolemia
Lipoproteins
Fibroblasts
Lipids
Clinical Studies

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

II. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia. / Bilheimer, D. W.; East, C.; Grundy, Scott M; Nora, J. J.

In: American Journal of Medical Genetics, Vol. 22, No. 3, 1985, p. 593-598.

Research output: Contribution to journalArticle

@article{12015022eed5487895025e38c76baeb8,
title = "II. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia",
abstract = "We have studied a family carrying a variant of the class 2 mutation of familial hypercholesterolemia (FH) in which there is unusual longevity and in which obligate heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes have the same kinetic defect in the processing of low density lipoprotein (LDL) receptors their fibroblasts and the reduced fractional catabolic rate for apoLDL that is characteristic of other patients with heterozygotes FH. However, their plasma lipid and lipoprotein levels are not as strikingly abnormal because they have normal or near normal rates of apoLDL synthesis.",
author = "Bilheimer, {D. W.} and C. East and Grundy, {Scott M} and Nora, {J. J.}",
year = "1985",
language = "English (US)",
volume = "22",
pages = "593--598",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - II. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia

AU - Bilheimer, D. W.

AU - East, C.

AU - Grundy, Scott M

AU - Nora, J. J.

PY - 1985

Y1 - 1985

N2 - We have studied a family carrying a variant of the class 2 mutation of familial hypercholesterolemia (FH) in which there is unusual longevity and in which obligate heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes have the same kinetic defect in the processing of low density lipoprotein (LDL) receptors their fibroblasts and the reduced fractional catabolic rate for apoLDL that is characteristic of other patients with heterozygotes FH. However, their plasma lipid and lipoprotein levels are not as strikingly abnormal because they have normal or near normal rates of apoLDL synthesis.

AB - We have studied a family carrying a variant of the class 2 mutation of familial hypercholesterolemia (FH) in which there is unusual longevity and in which obligate heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes did not express constant or statistically significant hypercholesterolemia. The heterozygotes have the same kinetic defect in the processing of low density lipoprotein (LDL) receptors their fibroblasts and the reduced fractional catabolic rate for apoLDL that is characteristic of other patients with heterozygotes FH. However, their plasma lipid and lipoprotein levels are not as strikingly abnormal because they have normal or near normal rates of apoLDL synthesis.

UR - http://www.scopus.com/inward/record.url?scp=0022270465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022270465&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 593

EP - 598

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -